🔸پذیرش مقالات مروری در کنگره #کنسرژنومیکس🔸
🔺در ابتدا برای آشنایی با نحوه نگارش مقالات مروری میتوانید به لینک زیر مراجعه کنید:
https://cgc2023.com/wp-content/uploads/2023/03/Review.pdf
🔺موضوعات خود را بر اساس فایل اکسل
زیر انتخاب کنید:
https://docs.google.com/spreadsheets/d/1Mowe_L8xn-UtDr2g-phlnGbAG6rfIGIHUGOH0u3K4vU/edit?usp=sharing
🔺ارائه شما میتواند به صورت پوستر یا سخنرانی باشد که انتخابش بر عهده شماست.
📌توجه کنید که محدودیت ظرفیت پذیرش پوستر و سخنرانی وجود دارد .
📩موضوعات مورد نظر خود را پس از انتخاب کردن از طریق شبکه های اجتماعی یا پیامک به خانم سمساری اطلاع دهید: 09355267821
♦️اگر ارائه شما به صورت سخنرانی باشد لازم است برای آن پاورپوینت آماده کنید و اگر به صورت پوستر باشد به یک ارائه شفاهی مورد نیاز است.
🔔مهلت ارسال چکیده مقالات : ۳۰ فروردین ماه
🔅با ما در اتباط باشید
🌐Website: WWW.CGC2023.COM
🔺LinkedIn: https://www.linkedin.com/showcase/cgc-2023
🔺Telegram Channel: t.iss.one/CGC_2023ad
🔺Instagram: https://instagram.com/cgc_2023?igshid=YmMyMTA2M2Y=
🔺در ابتدا برای آشنایی با نحوه نگارش مقالات مروری میتوانید به لینک زیر مراجعه کنید:
https://cgc2023.com/wp-content/uploads/2023/03/Review.pdf
🔺موضوعات خود را بر اساس فایل اکسل
زیر انتخاب کنید:
https://docs.google.com/spreadsheets/d/1Mowe_L8xn-UtDr2g-phlnGbAG6rfIGIHUGOH0u3K4vU/edit?usp=sharing
🔺ارائه شما میتواند به صورت پوستر یا سخنرانی باشد که انتخابش بر عهده شماست.
📌توجه کنید که محدودیت ظرفیت پذیرش پوستر و سخنرانی وجود دارد .
📩موضوعات مورد نظر خود را پس از انتخاب کردن از طریق شبکه های اجتماعی یا پیامک به خانم سمساری اطلاع دهید: 09355267821
♦️اگر ارائه شما به صورت سخنرانی باشد لازم است برای آن پاورپوینت آماده کنید و اگر به صورت پوستر باشد به یک ارائه شفاهی مورد نیاز است.
🔔مهلت ارسال چکیده مقالات : ۳۰ فروردین ماه
🔅با ما در اتباط باشید
🌐Website: WWW.CGC2023.COM
🔺LinkedIn: https://www.linkedin.com/showcase/cgc-2023
🔺Telegram Channel: t.iss.one/CGC_2023ad
🔺Instagram: https://instagram.com/cgc_2023?igshid=YmMyMTA2M2Y=
👍6❤5
🔴 آغاز ثبت نام عادی اولین کنگره بینالمللی کنسر ژنومیکس✨
🔰 آخرین مهلت ثبت نام و ارسال چکیده مقاله:
۳۰ فروردین ۱۴۰۲
اولین کنگره بینالمللی کنسر ژنومیکس با هدف توسعه مرزهای دانش، تجاریسازی یافتههای نوین محققین و ترویج شیوه زندگی سلامت ۱۳ تا ۱۵ اردیبهشت سال ۱۴۰۲، با همکاری بیش از ۲۲ انجمن علمی و ۶۰ انجمن علمی دانشجویی در سالن اجلاس سران برگزار خواهد شد.
محورهای کنگره:
🔺Molecular Diagnosis
🔺Personalized Medicine
🔺Targeted Therapy
🔹 دریافت مقالات به صورت چکیده
🔸 همراه با امتیاز بازآموزی
🔹 تا ۶۰ درصد تخفیف برای دانشجویان
🔸 برگزاری کارگاه، مسابقات و ...
📝 جهت کسب اطلاعات بیشتر از طریق شبکه های اجتماعی و یا سایت کنگره با ما در ارتباط باشید :
🔹 Telegram Group
🔸 LinkedIn
🔹 Instagram
🔸 Twitter
🔹 Whatsapp
🌐 Website:WWW.CGC2023.COM
🔰 آخرین مهلت ثبت نام و ارسال چکیده مقاله:
۳۰ فروردین ۱۴۰۲
اولین کنگره بینالمللی کنسر ژنومیکس با هدف توسعه مرزهای دانش، تجاریسازی یافتههای نوین محققین و ترویج شیوه زندگی سلامت ۱۳ تا ۱۵ اردیبهشت سال ۱۴۰۲، با همکاری بیش از ۲۲ انجمن علمی و ۶۰ انجمن علمی دانشجویی در سالن اجلاس سران برگزار خواهد شد.
محورهای کنگره:
🔺Molecular Diagnosis
🔺Personalized Medicine
🔺Targeted Therapy
🔹 دریافت مقالات به صورت چکیده
🔸 همراه با امتیاز بازآموزی
🔹 تا ۶۰ درصد تخفیف برای دانشجویان
🔸 برگزاری کارگاه، مسابقات و ...
📝 جهت کسب اطلاعات بیشتر از طریق شبکه های اجتماعی و یا سایت کنگره با ما در ارتباط باشید :
🔹 Telegram Group
🌐 Website:
❤8👍4
🔸Key Speaker:
Dr. Yasser Riazalhosseini
📍 Harnessing genomic data for precision medicine in renal cell carcinoma
🔹 About:
Yasser Riazalhosseini undertook his doctoral and post-doctoral training at the German Cancer Research Centre (DKFZ) in Heidelberg, Germany. At DKFZ, he developed systems biology approaches that combine genomics datasets from hundreds of cancers coupled with detailed clinical data, and high-throughput functional studies. In 2012, Dr. Riazalhosseini joined the Department of Human Genetics at McGill, and was appointed Group Head of the Cancer Genomics program at the McGill Genome Centre. His group pioneered genomic characterization of renal cell carcinoma (RCC) through integrative analysis of genome and transcriptome sequencing data in the context of the International Cancer Genome Consortium (ICGC).
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
Dr. Yasser Riazalhosseini
📍 Harnessing genomic data for precision medicine in renal cell carcinoma
🔹 About:
Yasser Riazalhosseini undertook his doctoral and post-doctoral training at the German Cancer Research Centre (DKFZ) in Heidelberg, Germany. At DKFZ, he developed systems biology approaches that combine genomics datasets from hundreds of cancers coupled with detailed clinical data, and high-throughput functional studies. In 2012, Dr. Riazalhosseini joined the Department of Human Genetics at McGill, and was appointed Group Head of the Cancer Genomics program at the McGill Genome Centre. His group pioneered genomic characterization of renal cell carcinoma (RCC) through integrative analysis of genome and transcriptome sequencing data in the context of the International Cancer Genome Consortium (ICGC).
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤6👏2
عزیزانی که از پژوهشگاه ملی مهندسی ژنتیک قصد ثبتنام داشتند عنوان این پژوهشگاه به لیست اضافه شد میتونن برای ثبت نام اقدام کنند 🌷
❤4
🔸Key Speaker:
Dr. Davood Bashash
📍 The PI3K signaling axis and its implication in human malignancies
🔹 About:
Dr. Bashash achieved his Ph.D. in hematology from Tehran University of Medical Science. Then he completed a fellowship in Clinical Laboratory Sciences at Iran University of Medical Science. He is also the research manager of the National Institute for Medical Research Development (NIMAD).
🔸 Associate Professor of Hematology at Shahid Beheshti University of Medical Sciences
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
Dr. Davood Bashash
📍 The PI3K signaling axis and its implication in human malignancies
🔹 About:
Dr. Bashash achieved his Ph.D. in hematology from Tehran University of Medical Science. Then he completed a fellowship in Clinical Laboratory Sciences at Iran University of Medical Science. He is also the research manager of the National Institute for Medical Research Development (NIMAD).
🔸 Associate Professor of Hematology at Shahid Beheshti University of Medical Sciences
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤5👍1👏1
Forwarded from انجمن علمی بیوتکنولوژی دانشگاه ازاد قم
💭برگزاری گپ و گفت دانشجویی🌺
🔺با موضوع فعالیت های انجمن علمی بیوتکنولوژی دانشگاه آزاد اسلامی واحد قم در یکسال اخیر
و معرفی کنگره بینالمللی کنسر ژنومیکس💡
زمان برگزاری: روز یکشنبه ۲۱ اسفند ماه ۱۴۰۱
ساعت ۱۱ الی ۱۲:۳۰🍃
مکان برگزاری : دانشکده علوم پایه 🍃
🧬🔬@biotechnology_qiau
🔺با موضوع فعالیت های انجمن علمی بیوتکنولوژی دانشگاه آزاد اسلامی واحد قم در یکسال اخیر
و معرفی کنگره بینالمللی کنسر ژنومیکس💡
زمان برگزاری: روز یکشنبه ۲۱ اسفند ماه ۱۴۰۱
ساعت ۱۱ الی ۱۲:۳۰🍃
مکان برگزاری : دانشکده علوم پایه 🍃
🧬🔬@biotechnology_qiau
👍8👎2
انجمن علمی بیوتکنولوژی دانشگاه ازاد قم
💭برگزاری گپ و گفت دانشجویی🌺 🔺با موضوع فعالیت های انجمن علمی بیوتکنولوژی دانشگاه آزاد اسلامی واحد قم در یکسال اخیر و معرفی کنگره بینالمللی کنسر ژنومیکس💡 زمان برگزاری: روز یکشنبه ۲۱ اسفند ماه ۱۴۰۱ ساعت ۱۱ الی ۱۲:۳۰🍃 مکان برگزاری : دانشکده علوم پایه 🍃 …
مرسی از بچه های پر انرژی بیوتک آزاد قم 👏👏👏
👏7
✨ Happy Nowruz 1402🌱🥳
برآمــــد باد صبـــح و بــــوی نــــوروز
به کـــــــام دوستان و بخــــت پیــروز
مبــارک بادت این ســال و همــه سـال
همــایــون بادت این روز و همـــه روز
با آرزوی سالی پر از خبرهای خوب ... 🌱✨
تیم کنگره بینالمللی کنسر ژنومیکس ❤️
🌐Website: WWW.CGC2023.COM
🔺LinkedIn: https://www.linkedin.com/showcase/cgc-2023
🔺Telegram Channel: t.iss.one/CGC_2023
🔺Instagram: https://instagram.com/cgc_2023?igshid=YmMyMTA2M2Y=
برآمــــد باد صبـــح و بــــوی نــــوروز
به کـــــــام دوستان و بخــــت پیــروز
مبــارک بادت این ســال و همــه سـال
همــایــون بادت این روز و همـــه روز
با آرزوی سالی پر از خبرهای خوب ... 🌱✨
تیم کنگره بینالمللی کنسر ژنومیکس ❤️
🌐Website: WWW.CGC2023.COM
🔺LinkedIn: https://www.linkedin.com/showcase/cgc-2023
🔺Telegram Channel: t.iss.one/CGC_2023
🔺Instagram: https://instagram.com/cgc_2023?igshid=YmMyMTA2M2Y=
❤12👍2
🔸Key Speaker:
DR. Sina Salari
📍 Curing cancer from within: the promise of cell therapy
🔹 About:
Doctor Sina Salari completed his specialty training in Internal Medicine at Tehran University and completed his 3 years fellowship in Hematology and Oncology at Shahid Beheshti Medical University. Between 2013 to 2019 he was the Director of the deputy of treatment of the Oncology-Hematology and BMT department, and Head of the internal department and responsible authorized physician of Ayatollah Taleghani Hospital. Dr.Salari has a particular interest in cell therapy and treatment of gastrointestinal malignancies. He is a member of the Iranian Cancer-Immunotherapy scientific committee and organized the first cancer Immunotherapy Conference in Iran in 2019.
🔸 Associate Professor of Medical Oncology-Hematology at Shahid Beheshti University of Medical Sciences.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
DR. Sina Salari
📍 Curing cancer from within: the promise of cell therapy
🔹 About:
Doctor Sina Salari completed his specialty training in Internal Medicine at Tehran University and completed his 3 years fellowship in Hematology and Oncology at Shahid Beheshti Medical University. Between 2013 to 2019 he was the Director of the deputy of treatment of the Oncology-Hematology and BMT department, and Head of the internal department and responsible authorized physician of Ayatollah Taleghani Hospital. Dr.Salari has a particular interest in cell therapy and treatment of gastrointestinal malignancies. He is a member of the Iranian Cancer-Immunotherapy scientific committee and organized the first cancer Immunotherapy Conference in Iran in 2019.
🔸 Associate Professor of Medical Oncology-Hematology at Shahid Beheshti University of Medical Sciences.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
👍4❤2
Forwarded from عکس نگار
🔺Message from
Prof. Salvatore Oliviero
🔸Co- scientific secretary of CCG2023
🔸 President, SIBBM
" I am pleased to welcome all participants to the First International Congress of Cancer Genomics on behalf of the Italian Society of Biophysics and Molecular Biology (SIBBM).
Cancer research and treatments have made significant progress in the recent years. The advancements of genomic analyses have made it possible to develop new targeted therapies. The progresses in gene and epigenetics editing and the novel developments in immunotherapy approaches are providing new important tools for the treatment of several malignancies. However, the mission to cure cancers is far to be accomplished. The continue development of basic research to investigate the molecular and cellular mechanisms is essential for the understanding of the complex network of regulations and instrumental for the dentification potential targets. The ongoing research is instrumental to understand the basis of the establishment and progression of cancer and certainly will lead the development of new cancer treatments. In the meeting we will have the opportunity to examine the state of the art of the ongoing studies and to explore the novel approaches which will lead us to render cancer curable. "
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
Prof. Salvatore Oliviero
🔸Co- scientific secretary of CCG2023
🔸 President, SIBBM
" I am pleased to welcome all participants to the First International Congress of Cancer Genomics on behalf of the Italian Society of Biophysics and Molecular Biology (SIBBM).
Cancer research and treatments have made significant progress in the recent years. The advancements of genomic analyses have made it possible to develop new targeted therapies. The progresses in gene and epigenetics editing and the novel developments in immunotherapy approaches are providing new important tools for the treatment of several malignancies. However, the mission to cure cancers is far to be accomplished. The continue development of basic research to investigate the molecular and cellular mechanisms is essential for the understanding of the complex network of regulations and instrumental for the dentification potential targets. The ongoing research is instrumental to understand the basis of the establishment and progression of cancer and certainly will lead the development of new cancer treatments. In the meeting we will have the opportunity to examine the state of the art of the ongoing studies and to explore the novel approaches which will lead us to render cancer curable. "
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤3🔥2
CGC2026
🔴 کنگره #کنسرژنومیکس برگزار میکند: 🔰 کارگاه تهیه ارائه علمی🔰 👨🏻🏫 مدرس:دکتر وحید عزتی زاده فوق دکترای ژنتیک و اپی ژنتیک سرطان 💳 هزینه شرکت در کارگاه :۳۰۰ هزارتومان 🔅 شرکت در کارگاه برای شرکت کنندگان در کنگره کنسر ژنومیکس رایگان میباشد. 📆 زمان:سه…
عزیزانی که در کنگره کنسر ژنومیکس ثبت نام کرده اند، از امشب با مراجعه به پنل کاربری خود میتوانند لینک دانلود ویدیو کارگاه ارائه علمی را دریافت نمایند.
بزودی سرتیفیکیت شرکت کنندگان نیز صادر خواهد شد 🌷
بزودی سرتیفیکیت شرکت کنندگان نیز صادر خواهد شد 🌷
🔥7👍5🤩1
CGC2026
عزیزانی که در کنگره کنسر ژنومیکس ثبت نام کرده اند، از امشب با مراجعه به پنل کاربری خود میتوانند لینک دانلود ویدیو کارگاه ارائه علمی را دریافت نمایند. بزودی سرتیفیکیت شرکت کنندگان نیز صادر خواهد شد 🌷
فقط یه نکته، اگر از دوستان کسی با جیمیل کاری یا اکانت شخص دیگری به کارگاه لاگین کرده بود لطفا اطلاع بده که سرتیفیکیت به نام خودش صادر بشه
به این ایدی اطلاع بدین: @CGC_2023ad
به این ایدی اطلاع بدین: @CGC_2023ad
🔸Key Speaker:
DR. Seyed Mahdi Jafarnejad
📍 Dysregulated mRNA Translation Initiation in Cancer
🔹 About:
Mehdi received his PhD in Experimental Medicine from The University of British Columbia in 2012, investigating the mechanisms of dysregulated microRNA biogenesis in melanomas. This was followed by a postdoctoral training stint at Goodman Cancer Centre at McGill University, studying the mechanisms of post-transcriptional regulation of gene expression. He joined the Patrick Johnston Centre for Cancer Research at Queen’s University Belfast in 2019 as a Principal Investigator. His group currently focuses on mechanisms of regulation of mRNA translation and decay, alterations in these mechanisms in cancer, and how these mechanisms contribute to therapy-resistance in cancer.Conference in Iran in 2019.
🔸 Area of research: Post-transcriptional regulation of gene expression
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
DR. Seyed Mahdi Jafarnejad
📍 Dysregulated mRNA Translation Initiation in Cancer
🔹 About:
Mehdi received his PhD in Experimental Medicine from The University of British Columbia in 2012, investigating the mechanisms of dysregulated microRNA biogenesis in melanomas. This was followed by a postdoctoral training stint at Goodman Cancer Centre at McGill University, studying the mechanisms of post-transcriptional regulation of gene expression. He joined the Patrick Johnston Centre for Cancer Research at Queen’s University Belfast in 2019 as a Principal Investigator. His group currently focuses on mechanisms of regulation of mRNA translation and decay, alterations in these mechanisms in cancer, and how these mechanisms contribute to therapy-resistance in cancer.Conference in Iran in 2019.
🔸 Area of research: Post-transcriptional regulation of gene expression
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤4
🔸Key Speaker:
DR. Lucia Altucci
📍 Targeting epigenome against cancer
🔹 About:
Lucia Alltucci is Full Professor of General Pathology at the University of Campania Luigi Vanvitelli and she is the Rector’s Delegate for Research. She is an MD,PhD with a specialisation in medical oncology. She is the elected President of all Italian Pathologists.Her contribution to the understanding of chromatin deregulation and epi-biomarkers in cancer as well as to the identification of innovative epi-strategies for cancer treatment and prevention are considered relevant.
She is Co-Editor in chief in the Clinical Epigenetics (Springer Nature) and Co-Editor in chief in the Epigenetics Communications (Springer Nature). She is member of the Traslational medicine PhD program which is constantly recruiting international candidates with a dedicated program for young women sci
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
DR. Lucia Altucci
📍 Targeting epigenome against cancer
🔹 About:
Lucia Alltucci is Full Professor of General Pathology at the University of Campania Luigi Vanvitelli and she is the Rector’s Delegate for Research. She is an MD,PhD with a specialisation in medical oncology. She is the elected President of all Italian Pathologists.Her contribution to the understanding of chromatin deregulation and epi-biomarkers in cancer as well as to the identification of innovative epi-strategies for cancer treatment and prevention are considered relevant.
She is Co-Editor in chief in the Clinical Epigenetics (Springer Nature) and Co-Editor in chief in the Epigenetics Communications (Springer Nature). She is member of the Traslational medicine PhD program which is constantly recruiting international candidates with a dedicated program for young women sci
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤8👍1
🔸Key Speaker:
DR. Ernesto Picardi
📍 Profiling the non-transient side of the epitranscriptome
🔹 About:
Ernesto Picardi is Full Professor in Molecular Biology at the University of Bari (Italy) and Research Associate at the Institute of Biomembranes and Bioenergetics (IBBE) of the National Research Council (CNR). He developed the first methodology to predict de novo RNA editing events by RNAseq data from Illumina as well as SOLiD platforms, and maintains the largest RNA editing collection in humans (REDIportal).
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
DR. Ernesto Picardi
📍 Profiling the non-transient side of the epitranscriptome
🔹 About:
Ernesto Picardi is Full Professor in Molecular Biology at the University of Bari (Italy) and Research Associate at the Institute of Biomembranes and Bioenergetics (IBBE) of the National Research Council (CNR). He developed the first methodology to predict de novo RNA editing events by RNAseq data from Illumina as well as SOLiD platforms, and maintains the largest RNA editing collection in humans (REDIportal).
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: WWW.CGC2023.COM
❤9👍1
🔸Key Speaker:
DR. Daniela Taverna
📍 miR-214 as coordinator of tumor-stroma crosstalk during
cancer progression and as therapeutic target
🔹 About:
Daniela Taverna has been carrying out research on neoplastic progression for more than thirty years, focusing on the identification of alterations that induce tumor cells to become aggressive and form metastases in distant organs. More recently her lab has generated molecular tools, called chimeric aptamers, able to target specific microRNAs responsible for metastasis. In Torino she worked first at the Institute for Cancer Research and Treatment (IRCCS) in Candiolo, then at Molecular Biotechnology Center (MBC), within the Department of Molecular Biotechnology and Health Sciences (DBMSS), where she still works now.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: www.cgc2023.com
DR. Daniela Taverna
📍 miR-214 as coordinator of tumor-stroma crosstalk during
cancer progression and as therapeutic target
🔹 About:
Daniela Taverna has been carrying out research on neoplastic progression for more than thirty years, focusing on the identification of alterations that induce tumor cells to become aggressive and form metastases in distant organs. More recently her lab has generated molecular tools, called chimeric aptamers, able to target specific microRNAs responsible for metastasis. In Torino she worked first at the Institute for Cancer Research and Treatment (IRCCS) in Candiolo, then at Molecular Biotechnology Center (MBC), within the Department of Molecular Biotechnology and Health Sciences (DBMSS), where she still works now.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: www.cgc2023.com
❤7👍1
🔸Key Speaker:
DR. Salvatore Oliviero
📍 DNA methylation specificity in Develeopment and Cancer
🔹 About:
Salvatore Oliviero is Professor in Molecular Biology at the University of Torino and head of the Laboratory of Epigenetomics at the Italian Institute for Genomic Medicine (IIGM) in Candiolo. From 2010 in Torino his lab focused on the regulation and function of DNA methylation in embryonic stem cells and in tumours. The main results of these studies led to the dissection of the functional interplay between the DNMTs and the Polycomb PRC2 complex to regulate the DNA methylation of developmental genes. The characterization of the DNA methylation dynamics in development and tumours.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: www.cgc2023.com
DR. Salvatore Oliviero
📍 DNA methylation specificity in Develeopment and Cancer
🔹 About:
Salvatore Oliviero is Professor in Molecular Biology at the University of Torino and head of the Laboratory of Epigenetomics at the Italian Institute for Genomic Medicine (IIGM) in Candiolo. From 2010 in Torino his lab focused on the regulation and function of DNA methylation in embryonic stem cells and in tumours. The main results of these studies led to the dissection of the functional interplay between the DNMTs and the Polycomb PRC2 complex to regulate the DNA methylation of developmental genes. The characterization of the DNA methylation dynamics in development and tumours.
✨ Social Media : @CGC_2023
✨ Tel Club: @CGC_2023club
🌐 Website: www.cgc2023.com
❤9